• 

  February 08, 2017

  BOOK LAUNCH FOR GRADIMIR GOJER IN BELGRADE

  Two books by Gradimir Gojer were launched at the Belgrade Center for Cultural Decontamination: Summa theatralica and Pjesni iz Vallarse [Poems from Vallarsa], published by the Gariwo NGO Kaleidoscope imprint. Borka Pavićević, dramaturge, Gorčin Stojanović, theater director, and Saša Ćirić, literary critic, spoke about Gojer's creative opus.

  VIŠE

• 

  February 04, 2017

  A PLEDGE FROM THE AUTHOR OF MORAL EXERCISES

  Predrag Matvejević was born in 1932 in Mostar. He earned his degree in French Language and Literature in Zagreb. In 1967 he defended his doctoral degree at the Sorbonne in Paris. He taught French Literature at the Faculty of Philosophy at Zagreb University until 1991 when he left Croatia. From 1991 to 1994 he taught Slavic literatures at the Nouvelle Sorbonne (Paris III), while from 1994 to 2007 he taught the Serbian and Croatian language and Serbian and Croatian literature at Sapienza University in Rome. He was author of numerous essays and books, including several with a bearing on the question of civil courage, such as "Open Letter - Moral Exercises." The titles which have been most widely translated are Mediteranski brevijar (English translation: Mediterranean: A Cultural Landscape), Druga Venecija (English translation: The Other Venice: Secrets of the City), and Jugoslavenstvo danas [Yugoslav Identity Today].

  VIŠE

• 

  January 24, 2017

  A CLASSICAL HERO LEAVES US

  In Memoriam

  VIŠE

• Choosing Between PDE5 Inhibitors: Why Patient Preference Defines Success in Erectile Dysfunction Therapy
• On-Demand Tadalafil in Asian Men with Erectile Dysfunction: Clinical Effectiveness, Cultural Context, and Practical Application
• Tamsulosin vs Tadalafil in BPH: A Modern Perspective on Treating Urinary and Sexual Health Together
• Tadalafil and Male Fertility: Rethinking PDE5 Inhibitors as Modulators of Spermatogenesis
• Tadalafil Beyond On-Demand: Rethinking Dosing Strategies in Erectile Dysfunction
• Scurvy and Pulmonary Hypertension: When a Forgotten Deficiency Mimics a Critical Cardiopulmonary Disease
• Tadalafil After Radical Prostatectomy: Rethinking Recovery Beyond Erectile Function
• Green Analytical Chemistry Meets Oncology: A Modern Framework for Simultaneous Drug Quantification
• Beyond Human Pharmacology: A New Frontier in PDE Inhibitor Discovery Using Yeast-Based Platforms
• Stuttering Priapism: From Rare Veterinary Observation to Broader Clinical Insight
• Tadalafil Beyond Erectile Dysfunction: Renal Protection in Chronic Kidney Disease
• Hyperlipidemia and Tadalafil: When Lipids Rewrite Pharmacokinetics
• Phosphodiesterase-5 Inhibitors and Hearing: An Underestimated Risk in Modern Pharmacotherapy
• Phosphodiesterase-5 Inhibitors in Dementia: From Vascular Drugs to Cognitive Modulators
• Sotatercept and the Changing Paradigm of Pulmonary Hypertension in Myeloproliferative Neoplasms
• Phosphodiesterase Type 5 Inhibitors Beyond Therapy: Clinical Utility, Misuse, and the Quiet Epidemic of Recreational Consumption
• Patient-Centered Therapy in Pulmonary Arterial Hypertension: Understanding Preferences in ERA and PDE5 Inhibitor Combination Treatment
• Thermal Imaging in Experimental Erectile Physiology: A Non-Invasive Revolution in Functional Assessment
• Tadalafil and Renal Protection: Integrating Nitric Oxide and Hydrogen Sulfide Signaling in Diabetic Podocyte Injury
• Tadalafil in Lifelong Premature Ejaculation: Rethinking Control Beyond Timing
• High-Dose Tadalafil Beyond Erectile Dysfunction: Insights Into Insulin Resistance and Metabolic Modulation
• Enhancing Tadalafil Bioavailability: The Emergence of Sono-Assisted Nanoemulsion Oral Jellies
• When PDE5 Inhibitors Are Not Enough: The RESPITE Approach to Optimizing Therapy in Pulmonary Arterial Hypertension
• Hidden Pharmacology in “Natural” Aphrodisiacs: Advanced Detection of Illegal Adulterants Using UHPLC–QTOF-MS
• Long-Term Tadalafil Therapy in Diabetic Erectile Dysfunction: The Role of Local Antioxidative Mechanisms
• Liposomal Delivery of PDE5 Inhibitors: A New Frontier in Microvascular Regulation and ATP Signaling
• Inflammation, Diabetes, and Erectile Dysfunction: Understanding the Role of High-Sensitivity C-Reactive Protein and the Therapeutic Impact of Tadalafil
• Tadalafil and the Eye: Understanding the Rare Risk of Anterior Ischemic Optic Neuropathy
• New Horizons in Pulmonary Arterial Hypertension Therapy: The Rise of Benzimidazole-Based PDE10 Inhibitors
• Precision in Pulmonary Arterial Hypertension Therapy: The Art and Science of Drug Titration
• Thermal Imaging in Experimental Andrology: A Modern Non-Invasive Method for Evaluating Erectile Function
• Beyond Serotonin: Can Tadalafil Enhance the Effect of Paroxetine in Premature Ejaculation?
• Phosphodiesterase Type 5 Inhibitors and the Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy: Separating Signal from Noise
• Daily 5 mg Tadalafil in Andropause: Beyond Erectile Function Toward Restored Quality of Life
• When Monotherapy Is Not Enough: The Clinical Impact of Adding Ambrisentan to PDE5 Inhibitors in Pulmonary Arterial Hypertension
• Treatment Patterns and Adherence in Pulmonary Arterial Hypertension: What Real-World Data Reveal About Persistence, Perception, and the Role of Tadalafil
• Tadalafil as a Chemoprotective Strategy Against Doxorubicin-Induced Hepatorenal Toxicity:
• Tadalafil After Nerve-Sparing Radical Prostatectomy: Does Daily Therapy Accelerate the Recovery of Erectile Function?
• Tadalafil and Generalized Bullous Fixed Drug Eruption: When a Common Drug Triggers a Rare and Serious Reaction
• Diketopiperazine-Based Flexible Tadalafil Analogues: Structural Innovation, Biological Evaluation, and Therapeutic Implications
• Tadalafil versus Tamsulosin in the Management of LUTS Suggestive of Benign Prostatic Hyperplasia: Clinical Parity, Functional Divergence, and Practical Decision-Making
• Pulmonary Hypertension in Silicosis with Pulmonary Artery Occlusion and Bronchial Anthracofibrosis: A Complex Vascular–Airway Intersection
• Tadalafil Orodispersible Film Versus Film-Coated Tablet: A Pharmacokinetic Equivalence Study and Its Clinical Implications
• National Prescription Trends for Male Lower Urinary Tract Symptoms and Erectile Dysfunction in Norway: A Two-Decade Perspective on Pharmacotherapy, Aging, and the Rise of Tadalafil
• Tadalafil as a Protective Modulator of Penile Nitric Oxide Synthase in SSRI-Induced Erectile Dysfunction: Translational Insights from a Rat Model
• Tadalafil in Egyptian and Turkish Men with Erectile Dysfunction: Clinical Efficacy, Cultural Context, and Practical Implications
• Tadalafil, Hypoxia, and Erectile Dysfunction: Lessons from a Murine Model of Sleep Apnea
• Tadalafil in the Comprehensive Management of Benign Prostatic Growth and Erectile Dysfunction: A Comparative Perspective Versus Tamsulosin
• Tadalafil and Cardiovascular Risk in Men with LUTS: A Potential Protective Association Against MACE and VTE
• Daily Tadalafil 5 mg in Benign Prostatic Hyperplasia: A Urological Therapy with Vascular Consequences
• When Efficacy Is Not Enough: Understanding Treatment Preference in Korean Men Switching from Sildenafil to Tadalafil
• Combination Therapy with Daily Tadalafil 5 mg and Tamsulosin 0.4 mg in Men with LUTS and Erectile Dysfunction: Does Metabolic Syndrome Change the Outcome?
• Intra-Meatal Tadalafil Cream Versus Oral Tadalafil: Rethinking Drug Delivery in Erectile Dysfunction Through a Randomized Cross-Over Clinical Trial

Who bears the most blame for the lack of civil courage?